NCT06076447Completed
Urdu Translation and Validation of MLHFQ
Cross-Cultural Adaptation and Validation of the Urdu Version of the Minnesota Living With Heart Failure Questionnaire (MLHFQ) Among Individuals With Heart Failure
Source: ClinicalTrials.gov · Last updated 19 Mar 2026
Brief summary (registry, in English)
* To translate the Minnesota Living with Heart Failure Questionnaire (MLHFQ) questionnaire into Urdu language of Pakistan. * To determine the validity and reliability of cross cultural adapted and Urdu translated MLHFQ questionnaire version among HF patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 210 (actual)
- First submitted
- 4 Oct 2023
- Start date
- 12 Nov 2023
- Primary completion date
- 30 Dec 2025
- Lead sponsor
- Riphah International University
- Diseases
- Heart failure
- NCT number
- NCT06076447
What you commit to
- Study type: Observational
- Participants enrolled: 210
- From 12 Nov 2023 to the primary completion date, 30 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Communication barriers or cognitive disorder as well as those with exacerbated condition and those who were not available for re-test were excluded from the study.
Other
- Decline consent
Who the study is looking for
- Patients with chronic heart failure who sought treatment at the outpatient cardiology clinic.
- Who could read and write in Urdu and English language and are willing to participate in the study.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Railway General Hospital Coordinator of this site? Confirm its status | Rawalpindi | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.